Mohajeri Maryam, Saghaei Lotfollah, Ghanadian Mustafa, Saberi Sedighe, Pestechian Nader, Ostadhusseini Ehsan
Department of Medicinal Chemistry, Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Department of Pharmacognosy, School of Pharmacy and Pharmaceutical Sciences, Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Adv Biomed Res. 2018 Apr 24;7:64. doi: 10.4103/abr.abr_76_17. eCollection 2018.
Today, leishmaniasis is a widespread, infectious parasitic disease caused by spp. Natural-derived compounds are likely to provide a valuable source of new pharmaceuticals, and among them, quercetin derivatives may have antileishmanial effects. The antileishmanial activity of 3,5,7,3',4'-pentahydroxyflavonol (quercetin) derivatives is partly attributed to the position and pKa of phenolic or catechol hydroxyl groups. Therefore, to optimize their leishmanicidal effect, the structural features of quercetin and its derivatives were improved by acylation or alkylation of hydroxyl groups and changing their pKa and consequently their activities.
In this study, during a regioselective method, quercetin derivatives were synthesized. The structures of synthesized compounds were confirmed by mass, IR, H-, and C-NMR spectral data. The antileishmanial activities of compounds 1-6 were compared with glucantime as the standard drug against promastigotes of using standard cell-based leishmanicidal assay.
In this study, during a regioselective method, two 7-O-quercetin derivatives (5 and 6), and three quercetin acetate derivatives (2, 3, and 4) were synthesized. In detail, the IC values found against were (1) 2.5 ± 0.92; (2) 2.85 ± 0.99; (3) 15.5 ± 1.95; (4) 13.5 ± 3.5; (5) 2.6 ± 0.57; and (6) 1.3 ± 0.35 μM while IC value of glucantime as the standard drug was 88.5 ± 9.47 μM.
The present study showed an effective antileishmanial activity of quercetin semisynthetic compounds (1-6) against promastigotes of . Among them, quercetin analogs with more lipophilic and iron-chelating activity showed more antiparasite activity.
如今,利什曼病是一种由利什曼原虫属物种引起的广泛传播的传染性寄生虫病。天然来源的化合物可能提供有价值的新药物来源,其中,槲皮素衍生物可能具有抗利什曼原虫的作用。3,5,7,3',4'-五羟基黄酮醇(槲皮素)衍生物的抗利什曼原虫活性部分归因于酚羟基或儿茶酚羟基的位置和pKa。因此,为了优化它们的杀利什曼原虫效果,通过羟基的酰化或烷基化以及改变它们的pKa从而改变其活性,对槲皮素及其衍生物的结构特征进行了改进。
在本研究中,采用区域选择性方法合成了槲皮素衍生物。通过质谱、红外光谱、氢谱和碳谱数据确认了合成化合物的结构。使用基于细胞的标准杀利什曼原虫试验,将化合物1 - 6的抗利什曼原虫活性与作为标准药物的葡糖胺锑钠针对杜氏利什曼原虫前鞭毛体的活性进行了比较。
在本研究中,采用区域选择性方法合成了两种7 - O - 槲皮素衍生物(5和6)以及三种槲皮素乙酸酯衍生物(2、3和4)。具体而言,针对杜氏利什曼原虫前鞭毛体发现的IC50值分别为:(1)2.5±0.92;(2)2.85±0.99;(3)15.5±1.95;(4)13.5±3.5;(5)2.6±0.57;(6)1.3±0.35 μM,而作为标准药物的葡糖胺锑钠的IC50值为88.5±9.47 μM。
本研究表明槲皮素半合成化合物(1 - 6)对杜氏利什曼原虫前鞭毛体具有有效的抗利什曼原虫活性。其中,具有更强亲脂性和铁螯合活性的槲皮素类似物表现出更强的抗寄生虫活性。